Navigation Links
Certain pain medications do not appear to be associated with skin cancer risk
Date:2/15/2010

Contrary to previous hypotheses, the use of non-steroidal anti-inflammatory drugs does not appear associated with risk of squamous cell skin cancer, according to a report posted online today that will appear in the April print issue of Archives of Dermatology, one of the JAMA/Archives journals.

Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen and celecoxib reduce pain and inflammation by blocking an enzyme involved in producing inflammatory compounds, according to background information in the article. NSAIDs may also inhibit the development of cancer cells by inducing cells to die and inhibiting the growth of new blood vessels.

Laboratory studies of cells and animals have indicated that NSAIDs protect against squamous cell carcinomas, common types of cancers that appear in the upper layers of the skin. However, while some studies have examined the associations between NSAIDs and other types of cancersincluding colorectal, breast, prostate and lungfew have assessed the association between NSAID use and squamous cell carcinoma risk in human populations.

Maryam M. Asgari, M.D., M.P.H., of Kaiser Permanente Northern California, Oakland, and colleagues studied 415 health plan members who were diagnosed with squamous cell carcinoma in 2004 and 415 control patients who were the same age, [Bleep] and race but had no history of skin cancer. Participants completed a questionnaire about NSAID use in the 10 years prior.

The majority of participants (61 percent) reported regular use of NSAIDs within the previous ten years, including 48 percent who used aspirin, 18 percent who used ibuprofen, 5 percent who used naproxen and 4 percent who used nabumetone.

"Regular use of any NSAID was not associated with a reduction in squamous cell carcinoma risk," the authors write. "Although NSAID users whose exposure was of short duration (one to three years) appeared to be at somewhat increased risk for squamou
'/>"/>

Contact: Maureen McInaney-Jones
maureen.mcinaney@kp.org
510-891-3173
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
2. Hypertension may predict dementia in older adults with certain cognitive deficits
3. G Marks the Spot: Good Vibrations Proclaims February as National G-Spot Month -- Sex Toy Company Says "It Most Certainly Does Exist!"
4. Mount Sinai finds prenatal exposure to certain chemicals affects childhood neurodevelopment
5. Video Games Could Boost Certain Thinking Skills
6. Swine Flu Wanes, But Future Uncertain
7. Certain Childhood Cancers More Likely to Recur
8. Greater certainty in monitoring 3 therapeutic medications is facilitated by new CRMs
9. Certain Reflux Drugs Tied to Higher Post-Angioplasty Death Rate
10. FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings
11. Increased success a virtual certainty for rugby players
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... ... Every summer, the public is reminded to leave the Fourth of July fireworks ... neighborhoods. Unfortunately, according to a recent report issued by the U.S. Consumer Product Safety ... Injuries Caused by Fireworks Doubled in Last 3 Years ," the number of fireworks-related ...
(Date:7/28/2015)... ... 28, 2015 , ... The PULs Cardiac Testâ„¢ identifies asymptomatic ... many of whom are missed by conventional evaluation , A currently unmet ... sub-clinical disease, who are at risk of experiencing a coronary event, and for ...
(Date:7/28/2015)... ... 28, 2015 , ... There has been much discussion in Washington, D.C. ... railroads, often overlooked is the over 740,000 miles of municipal sewer lines ... treatment facilities. According to the American Society of Civil Engineers , the average ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... provider announced HeartPlace will be expanding their cloud presence to support their rapidly ... groups in North Texas, has been serving the Dallas/Fort Worth area for almost ...
(Date:7/28/2015)... ... July 28, 2015 , ... Advanced Fertility Center ... inception in 2010, and Dr Dozortsev , a Reproductive Laboratory Director at ... In 2012, he was succeeded by Dr Gianpiero Palermo, who is credited with the ...
Breaking Medicine News(10 mins):Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3Health News:HeartPlace Announces Cloud Expansion with VAZATA 2Health News:HeartPlace Announces Cloud Expansion with VAZATA 3Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2
... 3 /PRNewswire-FirstCall/ - Two of DiagnoCure Inc.,(TSX: CUR) products, ... GCC for the staging of colorectal cancer, were discussed ... to molecular diagnostics., Yesterday, on June 2nd, DiagnoCure ... Assay Society Meeting, held in Coral,Springs, Florida, with a ...
... safe in both HIV-infected and HIVuninfected men , ... HIV disease, according to research published in PLoS Medicine. ... circumcision in the rural Rakai district of Uganda, Ron ... Hopkins University and colleagues found approximately a 3% rate ...
... Grant Will Fund Chicago Latino Outreach Program and National Latino ... ... The American Diabetes,Association (ADA) was recently awarded a $450,000 grant from ... National Latino,Outreach Toolkit. Diabetes is an urgent health problem in the ...
... Inc.,(NYSE: MED ) announced today that Michael S. ... a presentation at the,Canaccord Adams Diabetes & Obesity Conference ... the Hotel Nikko San Francisco., Interested parties can ... http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2301640 . The web,cast will be available for 60 ...
... precursors of autoantibody-secreting cells, have emerged as promising ... arthritis (RA). In particular, B cell depletion ... for RA patients resistant to standard disease-modifying antirheumatic ... blockers. In large trials, about half of ...
... 2 Katzen Eye Group is happy to,announce ... CRT.,Paragon CRT temporarily corrects nearsightedness (myopia) with or ... health of their patients, Katzen Eye Group is,continually ... vision care. Paragon CRT is a specially designed ...
Cached Medicine News:Health News:DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings 2Health News:DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings 3Health News:Study finds circumcision safe in both HIV-infected and HIV-uninfected men 2Health News:Study finds circumcision safe in both HIV-infected and HIV-uninfected men 3Health News:American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives 2Health News:Medifast, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference 2Health News:Study of anti-CD20 therapy effective B cell depletion 2Health News:Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 2
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or ... that it has received final approval for its common shares ... Exchange (the "TSX"). The Company,s common shares will commence trading ... under the trading symbol ,EPI,.  Concurrently, ESSA,s common shares will ... About ESSA Pharma Inc. ESSA Pharma is a ...
(Date:7/28/2015)... 2015 According to a new market ... Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration ... to 2020", published by MarketsandMarkets, the European Injectable Drug Delivery ... $114.7 Billion in 2015, growing at a CAGR of 12.6% ... 230 market data T ables and ...
(Date:7/27/2015)... and PARIS , July ...  and Sanofi have entered into a new global ... treatments in the emerging field of immuno-oncology. As part ... a programmed cell death protein 1 (PD-1) inhibitor currently ... trials in 2016 with new therapeutic candidates based on ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8
EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention th...
... a key participant in the area of ... decade. Previous Medtronic autotransfusion systems allowed clinicians ... well as to determine requirements for a ... (PRP) for a small amount of autologous ...
... SJM Pericardial Patch with EnCap technology ... vessel reconstruction/repair and for pericardial closure. ... offers surgeons durability and flexibility, plus ... patches. Equally important in a tissue ...
... triaxial catheter design and ergonomic handle ... proprietary radiopaque Nitinol markers on the ... stent enhance visibility. Corrugated ring design ... the nested ring pattern minimizes stent ...
Medicine Products: